Similar Search Results

Payments, promotion, and the purple pill

Ridley, David B. - In: Health economics 24 (2015) 1, pp. 86-103

Persistent link: https://www.econbiz.de/10011316672

Pharmaceutical promotion and GP prescription behaviour

Windmeijer, Frank; Laat, Eric A. A. de; Douven, Rudy; … - 2004

Persistent link: https://www.econbiz.de/10002004677

Do pharmaceutical marketing activities raise prices? : evidence from five major therapeutic classes

Capella, Michael L.; Taylor, Charles Raymond; Campbell, … - In: Journal of public policy & marketing : JPP & M ; an … 28 (2009) 2, pp. 146-161

Persistent link: https://www.econbiz.de/10003923111

Pharmaceutical promotion and GP prescription behaviour

Windmeijer, Frank; Laat, Eric A. A. de; Douven, Rudy; … - In: Health economics 15 (2006) 1, pp. 5-18

Persistent link: https://www.econbiz.de/10003274073

Pharmaceutical demand response to utilization management

Sarig, Oren - In: Journal of health economics 93 (2024), pp. 1-18

Persistent link: https://www.econbiz.de/10014451293

Pharmaceutical Promotion and Gp Prescription Behaviour

Windmeijer, Frank; de Laat, Eric; Douven, Rudy; Mot, Esther - 2006

The aim of this paper is to empirically analyse the responses by general practitioners to promotional activities for ethical drugs by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be harmful in the sense that it lowers price...

Persistent link: https://www.econbiz.de/10014058923